Furthermore, aforementioned anti-BPI antibodies have the potential to block the protective effects of BPI against LPS which causes vascular endothelial cell injury and, in so doing, facilitates blood vessels inflammation and vasculitis (9). This evidence concerns the gene BPI and vasculitis.